Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Cyclacel Pharmaceuticals, Inc. (CYCC) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.08M |
|
-- |
|
-- |
|
$5.04M |
|
$-5.04M |
|
$4.96M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-0.08M |
|
$-5.04M |
|
$-5.04M |
|
0.00M |
|
0.00M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$3.71M |
|
$0.00M |
|
$0.02M |
|
$3.73M |
|
$0.66M |
|
-- |
|
$0.01M |
|
$0.67M |
|
$3.06M |
|
$3.06M |
|
$3.06M |
|
207.34M |
|
| Cash Flow Statement Financials | |
$-3.25M |
|
-- |
|
$3.65M |
|
$3.14M |
|
$3.45M |
|
$0.31M |
|
$1.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.60 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.65% |
|
-2.65% |
|
-2.17% |
|
-2.65% |
|
$0.01 |
|
-- |
|
-- |
|